PAMAfrica
Portfolio approach to developing the next-generation of malaria treatments for Africa
This project is part of the EDCTP2 Programme supported by the European Union.
EDCTP
EU
Search
Search
English
\n
Español
\n
Français
\n
Search
Search
Toggle main menu visibility
About us
What we do
Governance
PAMAfrica scientists
PAMAfrica students
Work packages
Next-generation drug combination for uncomplicated malaria
First malaria treatment for babies under 5kg
New medicine for treatement of severe malaria
Building research capacity
Consortium partners
Newsroom
Resources
News
Search
Home
About us
PAMAfrica scientists
PAMAfrica scientists
1
Dr Yeka Adoke
Ph.D, Director and Principal Investigator at IDRC (WP 1)
Miss Sarita Barsainya
Masters in Pharmacy, Global Trial Director at Novartis (WP 3)
Dr Quique Bassat
PhD, Head of the Malaria Programme at ISGlobal (WP 2)
Dr Helen Demarest
PhD, Director, Clinical Operations for MMV (WP 4)
Dr Ghyslain Mombo-Ngoma
MD, PhD, Head of Clinical Operations at CERMEL (WP 1 - WP 3)
Dr Alphonse Ouédraogo
MD, PhD, Senior Field Coordinator at GRAS (WP 1 - WP 3)
Dr Celine Risterucci
PhD, Global Clinical Development Director at Novartis (WP 2)
Dr Alfred Tiono
MD, PhD, Associate Researcher at GRAS (WP 1 - WP 3)
Dr Rella Zoleko Manego
MD,MPH, Clinical Researcher at CERMEL (WP 1 - WP 3)
